These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 19239388)

  • 1. Nanostructured lipid carrier-based hydrogel formulations for drug delivery: a comprehensive review.
    Doktorovova S; Souto EB
    Expert Opin Drug Deliv; 2009 Feb; 6(2):165-76. PubMed ID: 19239388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanostructuring lipid carriers using Ridolfia segetum (L.) Moris essential oil.
    Miranda M; Cruz MT; Vitorino C; Cabral C
    Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109804. PubMed ID: 31349527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Miconazole-loaded nanostructured lipid carriers (NLC) for local delivery to the oral mucosa: improving antifungal activity.
    Mendes AI; Silva AC; Catita JA; Cerqueira F; Gabriel C; Lopes CM
    Colloids Surf B Biointerfaces; 2013 Nov; 111():755-63. PubMed ID: 23954816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the physical stability of SLN and NLC before and after incorporation into hydrogel formulations.
    Souto EB; Wissing SA; Barbosa CM; Müller RH
    Eur J Pharm Biopharm; 2004 Jul; 58(1):83-90. PubMed ID: 15207541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QbD guided early pharmaceutical development study: Production of lipid nanoparticles by high pressure homogenization for skin cancer treatment.
    Amasya G; Aksu B; Badilli U; Onay-Besikci A; Tarimci N
    Int J Pharm; 2019 May; 563():110-121. PubMed ID: 30935913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
    Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulations based on solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for cutaneous use: A review.
    Garcês A; Amaral MH; Sousa Lobo JM; Silva AC
    Eur J Pharm Sci; 2018 Jan; 112():159-167. PubMed ID: 29183800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minoxidil-loaded nanostructured lipid carriers (NLC): characterization and rheological behaviour of topical formulations.
    Silva AC; Santos D; Ferreira DC; Souto EB
    Pharmazie; 2009 Mar; 64(3):177-82. PubMed ID: 19348340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanostructured lipid carriers for transdermal delivery of acid labile lansoprazole.
    Lin WJ; Duh YS
    Eur J Pharm Biopharm; 2016 Nov; 108():297-303. PubMed ID: 27449633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physicochemical characterization and in vitro release studies of ascorbyl palmitate-loaded semi-solid nanostructured lipid carriers (NLC gels).
    Teeranachaideekul V; Souto EB; Müller RH; Junyaprasert VB
    J Microencapsul; 2008 Mar; 25(2):111-20. PubMed ID: 18246489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanostructured lipid carriers as semisolid topical delivery formulations for diflucortolone valerate.
    Abdel-Salam FS; Mahmoud AA; Ammar HO; Elkheshen SA
    J Liposome Res; 2017 Mar; 27(1):41-55. PubMed ID: 26956098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clotrimazole-loaded nanostructured lipid carrier hydrogels: thermal analysis and in vitro studies.
    Ravani L; Esposito E; Bories C; Moal VL; Loiseau PM; Djabourov M; Cortesi R; Bouchemal K
    Int J Pharm; 2013 Oct; 454(2):695-702. PubMed ID: 23792467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanostructured Lipid Carriers (NLC)-Based Gel Formulations as Etodolac Delivery: From Gel Preparation to Permeation Study.
    Czajkowska-Kośnik A; Szymańska E; Winnicka K
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical delivery of dexamethasone acetate from hydrogel containing nanostructured liquid carriers and the drug.
    Tung NT; Huyen VT; Chi SC
    Arch Pharm Res; 2015 Nov; 38(11):1999-2007. PubMed ID: 25940221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SLN and NLC for topical, dermal, and transdermal drug delivery.
    Souto EB; Baldim I; Oliveira WP; Rao R; Yadav N; Gama FM; Mahant S
    Expert Opin Drug Deliv; 2020 Mar; 17(3):357-377. PubMed ID: 32064958
    [No Abstract]   [Full Text] [Related]  

  • 16. Nanostructured lipid carriers: A potential use for skin drug delivery systems.
    Czajkowska-Kośnik A; Szekalska M; Winnicka K
    Pharmacol Rep; 2019 Feb; 71(1):156-166. PubMed ID: 30550996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications and limitations of lipid nanoparticles in dermal and transdermal drug delivery via the follicular route.
    Lauterbach A; Müller-Goymann CC
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):152-63. PubMed ID: 26144664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of SLN and NLC as topical particulate carriers for imidazole antifungal agents.
    Souto EB; Müller RH
    Pharmazie; 2006 May; 61(5):431-7. PubMed ID: 16724541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study between the viscoelastic behaviors of different lipid nanoparticle formulations.
    Souto EB; Wissing SA; Barbosa CM; Müller RH
    J Cosmet Sci; 2004; 55(5):463-71. PubMed ID: 15608996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural Lipids as Structural Components of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Topical Delivery.
    Dobreva M; Stefanov S; Andonova V
    Curr Pharm Des; 2020; 26(36):4524-4535. PubMed ID: 32410552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.